Status:
UNKNOWN
Sclerostin and Vascular Calcification in CKD and Renal Transplant
Lead Sponsor:
Ahmed Faisal Mohamed Mohamed Saleh
Conditions:
Vascular Calcification
Chronic Kidney Failure
Eligibility:
All Genders
18-70 years
Brief Summary
the aim of the research is to determine the degree of vascular calcification in chronic kidney disease and post-transplant and whether there is a correlation with the level of serum sclerostin.
Detailed Description
Sclerostin is a 22-kDa glycoprotein encoded by the SOST gene. This glycoprotein is almost exclusively synthesized by osteocytes that are not present near the bone surface but lie in the mineralized co...
Eligibility Criteria
Inclusion
- Chronic Kidney disease stages 4 and 5
- Renal transplant recipients
Exclusion
- Significant co-morbidity: advanced cancer, advanced liver disease, tertiary hyperparathyroidism
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04066855
Start Date
December 1 2019
End Date
September 1 2020
Last Update
August 26 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.